A
$ Value
$0
Shares
32,000
Price
$0
Filed
Jan 22
Insider
Name
Stelzer Laurie
Title
—
CIK
0001644348
Roles
Director
Transaction Details
Transaction Date
2026-01-20
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
32,000
Footnotes
One-third of the shares underlying this option will vest and become exercisable on January 20, 2027, the anniversary of the date of grant, with the remainder vesting monthly over the subsequent two year period, subject to the Reporting Person's continued service on each such vesting date.
Filing Info
Stelzer Laurie's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-20 | MBX | A | $0 |
| 2025-06-12 | SION | A | $0 |
| 2025-06-05 | PMVP | A | $0 |
| 2025-05-29 | SYRE | A | $0 |
Other Insiders at MBX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Hawryluk P. Kent
President & CEO
|
$526K | — | 2026-03-13 |
| Hoerter Steven L. | — | — | 2025-11-22 |
|
Bartram Richard
Chief Financial Officer
|
— | — | 2026-02-02 |
|
Azoulay Salomon
Chief Medical Officer
|
— | — | 2026-02-02 |